Ledger.Open graph →
SEC Form D · filed November 29, 2017

BreStem Therapeutics, Inc

Offering
$2.0M
Sold
$50K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
RALEIGH, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Dongmei Zhu · Raleigh, NCExecKe Cheng · Raleigh, NCExec · DirectorKinneret L. Savitzky · Holon, L3ExecAnat Cohen-Dayag · Holon, L3Exec · DirectorDavid Briskie · Chula Vista, CAExecChad Feigel · Chicago, ILExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗